首页 | 本学科首页   官方微博 | 高级检索  
检索        

慢性粒细胞白血病患者树突状细胞抗原加工递呈和迁移功能观察
引用本文:张琳,周健,胡杰英.慢性粒细胞白血病患者树突状细胞抗原加工递呈和迁移功能观察[J].郑州大学学报(医学版),2006,41(5):895-897.
作者姓名:张琳  周健  胡杰英
作者单位:郑州大学第五附属医院检验科,郑州,450052;河南省肿瘤医院血液科,郑州,450008
摘    要:目的:研究细胞因子体外联合诱导培养的慢性粒细胞白血病(CML)患者树突状细胞(DCs)的表型和抗原递呈、分泌和迁移功能的变化.方法:分离CML患者(CML组)和健康志愿者(正常组)外周血单个核细胞(PMNCs),经培养获取贴壁细胞,将CML组和正常组的贴壁细胞及K562细胞用细胞因子rhGM-CSF、rhIL-4、TNF-α体外诱导10 d后,流式细胞仪检测细胞的免疫表型;培养5 d后,用ELISA检测细胞的内吞功能;应用混合淋巴细胞培养分析3组DCs对静息T细胞的免疫刺激活性.结果:正常组、CML组、K562组DCs的特异性标志CD83和共刺激分子标记CD80和CD86以及CD11和HLA-DR的表达差异无统计学意义(P>0.05);DCs的抗原吞噬、迁移能力和对T细胞的免疫刺激活性,CML组和K562组之间差异无统计学意义(P>0.05),CML组和正常组间差异有统计学意义(P<0.05).结论:CML患者DCs的免疫表型和正常人相似,但其抗原捕获、递呈和迁移功能有缺陷.

关 键 词:慢性粒细胞白血病  树突状细胞  抗原递呈  迁移
收稿时间:2006-04-20
修稿时间:2006年4月20日

Investigation on antigen processing and presentation, migration ability of dendritic cells in vitro from chronic myeloid leukemia patients
ZHANG Lin,ZHOU Jian,HU Jieying.Investigation on antigen processing and presentation, migration ability of dendritic cells in vitro from chronic myeloid leukemia patients[J].Journal of Zhengzhou University: Med Sci,2006,41(5):895-897.
Authors:ZHANG Lin  ZHOU Jian  HU Jieying
Institution:1.Department of Clinical Laboratory, the Fifth Affiliated Hospital, Zhengzhou University, Zhengzhou 450052; 2 . Department of Hematology, Henan Tumor Hospital, Zhengzhou 450008
Abstract:Aim: To study the antigen processing and presentation, secretion, and migration ability of dendritic cells(DCs) from chronic myeloid leukemia (CML) patients. Methods:The differentiation of DCs generated from CD34 progenitor cells was mediated by cytokines like granulocyte macrophage colony-stimulating factor, tumor necrosis factor, interleukin-4. Maturation status of CML DCs and normal DCs were evaluated by the surface marker using flow cytometry. Ability of DCs to stimulate T cells and capture antigen were detected using a liquid-scintillation counter and ELISA.Results: Phenotypic analysis of CML and normal DCs showed a similar surface expression of maturation makers of CD80, CD86, CD83, CD11, and HLA-DR (P>0.05). There are statistical differences in the capacity of T cells activation, endocytosis or phagocytosis and transmigration between DCs derived from CML patients and healthy individuals.Conclusion: DCs derived from both healthy subjects and patients with CML differentiated and matured cultured in vitro in a similar way. However, DCs generated from CML patients have a reduced capacity to capture,process and present antigen and migration when compared with DCs from healthy controls.
Keywords:chronic myeloid leukemia  dendritic cell  antigen presentation  migration
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号